Description
RADIOPHARMACEUTICAL: AXUMIN AMYVID RADIOISOTOPE
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-04-16+$390,852= $390,852
- Mod P000012021-09-21+$427,686= $818,538
- Mod P000022022-11-29-$99,850= $718,688
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-04-16 | +$390,852 | $390,852 | RADIOPHARMACEUTICAL: AXUMIN AMYVID RADIOISOTOPE |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-09-21 | +$427,686 | $818,538 | RADIOPHARMACEUTICAL: AXUMIN AMYVID RADIOISOTOPE |
| Mod P00002· FUNDING ONLY ACTION | 2022-11-29 | −$99,850 | $718,688 | RADIOPHARMACEUTICAL: AXUMIN AMYVID RADIOISOTOPE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI Z63RLN31BEE5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24726P0726 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q527 · MEDICAL- NUCLEAR MEDICINE | $1,575,677 | FY2026 |
| 36C25726P0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $40,573 | FY2026 |
| 36C24726C0041 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q527 · MEDICAL- NUCLEAR MEDICINE | $288,295 | FY2026 |
| 36C24726P0609 | 247-NETWORK CONTRACT OFFICE 7 (36C247) · Q522 · MEDICAL- RADIOLOGY | $241,418 | FY2026 |
| 36C24226N0561 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $226,562 | FY2026 |
| 36C24226D0062 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24826F0207 | CSL BEHRING L.L.C. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $183,903 | FY2026 |
| 36C24826P1108 | ASD SPECIALTY HEALTHCARE, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $54,600 | FY2026 |
| 36C24826P1090 | SIRTEX MEDICAL INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $45,825 | FY2026 |
| 36C24826N0511 | BIOMERIEUX INC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $61,788 | FY2026 |
| 36C24826N0693 | MEDI-PHYSICS, INC. | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $111,150 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24821N0558_3600_36C24821D0041_3600 · retrieved 2026-09-26.